AF
FLGT icon

Amalgamated Financial’s Fulgent Genetics FLGT Stock Holding History

Amalgamated Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$562K Buy
+9,011
New +$593K ﹤0.01% 1463

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Financial's FLGT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Fulgent Genetics (FLGT) in Q1 2022: 9,011 shares worth $562K. The stake represents ﹤0.01% of the portfolio and ranks #1463 among its holdings.

275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • Amalgamated Financial held 9,011 shares of Fulgent Genetics worth $562K as of Q1 2022.
  • Fulgent Genetics was a new Amalgamated Financial position in Q1 2022.
  • Fulgent Genetics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1463 holding.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.